Weiqing He

506 total citations
33 papers, 396 citations indexed

About

Weiqing He is a scholar working on Molecular Biology, Pharmacology and Biotechnology. According to data from OpenAlex, Weiqing He has authored 33 papers receiving a total of 396 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 19 papers in Pharmacology and 4 papers in Biotechnology. Recurrent topics in Weiqing He's work include Microbial Natural Products and Biosynthesis (19 papers), RNA and protein synthesis mechanisms (8 papers) and Genomics and Phylogenetic Studies (6 papers). Weiqing He is often cited by papers focused on Microbial Natural Products and Biosynthesis (19 papers), RNA and protein synthesis mechanisms (8 papers) and Genomics and Phylogenetic Studies (6 papers). Weiqing He collaborates with scholars based in China, United States and United Kingdom. Weiqing He's co-authors include Chung‐Dar Lu, Yiguang Wang, Congran Li, Jian Lei, Yuying Liu, Yu Du, Hongyuan Wang, Qunjie Gao, Guoqing Li and Zhili Lu and has published in prestigious journals such as Scientific Reports, Journal of Bacteriology and International Journal of Molecular Sciences.

In The Last Decade

Weiqing He

33 papers receiving 388 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Weiqing He China 12 274 166 55 49 44 33 396
Olivier Kerbarh United Kingdom 13 278 1.0× 81 0.5× 29 0.5× 49 1.0× 34 0.8× 14 393
Srikannathasan Velupillai United Kingdom 11 374 1.4× 58 0.3× 25 0.5× 33 0.7× 21 0.5× 14 622
Soyoung Min Ireland 12 447 1.6× 43 0.3× 28 0.5× 50 1.0× 42 1.0× 16 729
Ross Zirkle United States 10 355 1.3× 203 1.2× 92 1.7× 64 1.3× 97 2.2× 13 530
Ling‐Jie Gao Belgium 13 252 0.9× 114 0.7× 16 0.3× 55 1.1× 36 0.8× 31 546
Shilah A. Bonnett United States 10 242 0.9× 86 0.5× 15 0.3× 27 0.6× 29 0.7× 17 344
Maria S. Brown United States 9 195 0.7× 58 0.3× 52 0.9× 22 0.4× 18 0.4× 16 304
Tore Duvold Denmark 10 296 1.1× 121 0.7× 21 0.4× 26 0.5× 18 0.4× 16 471
H Shimada Japan 14 267 1.0× 92 0.6× 17 0.3× 45 0.9× 40 0.9× 34 506
Bala Krishna Prabhala Denmark 10 213 0.8× 65 0.4× 27 0.5× 20 0.4× 10 0.2× 29 337

Countries citing papers authored by Weiqing He

Since Specialization
Citations

This map shows the geographic impact of Weiqing He's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weiqing He with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weiqing He more than expected).

Fields of papers citing papers by Weiqing He

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Weiqing He. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weiqing He. The network helps show where Weiqing He may publish in the future.

Co-authorship network of co-authors of Weiqing He

This figure shows the co-authorship network connecting the top 25 collaborators of Weiqing He. A scholar is included among the top collaborators of Weiqing He based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Weiqing He. Weiqing He is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhong, Xiuli, Jianrui Li, Weiqing He, et al.. (2025). Synthesis and evolution of 16-membered macrolide carrimycin derivatives as a novel class of anti-HCoV-OC43 agents targeting viral FSE RNA. European Journal of Medicinal Chemistry. 287. 117373–117373. 2 indexed citations
2.
Zhang, Na, Yiming Li, Simin Guo, et al.. (2024). Isovalerylspiramycin I alleviates liver injury and liver fibrosis by targeting the nucleotide-binding protein 2 (NUBP2)-vascular non-inflammatory molecule-1 (VNN1) pathway. Journal of Pharmaceutical Analysis. 15(3). 101048–101048. 2 indexed citations
3.
Cui, Jing, Jingcheng Zhou, Weiqing He, et al.. (2022). Targeting selenoprotein H in the nucleolus suppresses tumors and metastases by Isovalerylspiramycin I. Journal of Experimental & Clinical Cancer Research. 41(1). 126–126. 20 indexed citations
4.
He, Weiqing, et al.. (2020). Enzymatic synthesis of myricetin 3-O-galactoside through a whole-cell biocatalyst. Chinese Herbal Medicines. 12(4). 384–389. 6 indexed citations
5.
Lu, Zhili, et al.. (2019). Engineering of leucine-responsive regulatory protein improves spiramycin and bitespiramycin biosynthesis. Microbial Cell Factories. 18(1). 38–38. 18 indexed citations
6.
Zhang, Xiaoting, et al.. (2019). [Construction of a new isovalerylspiramycin I producing strain by CRISPR-Cas9 system].. PubMed. 35(3). 472–481. 1 indexed citations
7.
Lu, Zhili, et al.. (2017). Identification of two regulatory genes involved in carbomycin biosynthesis in Streptomyces thermotolerans. Archives of Microbiology. 199(7). 1023–1033. 6 indexed citations
8.
He, Weiqing, Chunping Yang, Xiaofeng Zhao, & Yiguang Wang. (2017). Antimicrobial activity of bitespiramycin, a new genetically engineered macrolide. Bioorganic & Medicinal Chemistry Letters. 27(19). 4576–4577. 11 indexed citations
9.
Li, Quanjie, Shuai Fan, Xiaoyu Li, et al.. (2016). Insights into the Phosphoryl Transfer Mechanism of Human Ubiquitous Mitochondrial Creatine Kinase. Scientific Reports. 6(1). 38088–38088. 12 indexed citations
10.
He, Weiqing, et al.. (2013). Inactivation of putative PKS genes can double geldanamycin yield in Streptomyces hygroscopicus 17997. Genetics and Molecular Research. 12(2). 2076–2085. 2 indexed citations
11.
Jiang, Bingya, Yiguang Wang, Hongxia Zhou, et al.. (2013). Identification of 6-demethoxy-6-methylgeldanamycin and its implication of geldanamycin biosynthesis. The Journal of Antibiotics. 67(2). 183–185. 4 indexed citations
12.
Chen, Feifei, Ling Lin, Lu Wang, et al.. (2011). Distribution of dTDP-glucose-4,6-dehydratase gene and diversity of potential glycosylated natural products in marine sediment-derived bacteria. Applied Microbiology and Biotechnology. 90(4). 1347–1359. 16 indexed citations
13.
Lin, Ling, et al.. (2011). Novel 4,5-Dihydro-thiazinogeldanamycin in agdmPMutant Strain ofStreptomyces hygroscopicus17997. Bioscience Biotechnology and Biochemistry. 75(10). 2042–2045. 10 indexed citations
14.
Liu, Xin, Jingyan Li, Hongyuan Wang, et al.. (2011). A pair of sulfur-containing geldanamycin analogs, 19-S-methylgeldanamycin and 4,5-dihydro- 19-S-methylgeldanamycin, from Streptomyces hygroscopicus 17997. The Journal of Antibiotics. 64(7). 519–522. 12 indexed citations
15.
Wang, Hongyuan, et al.. (2011). Thiazinogeldanamycin, a New Geldanamycin Derivative Produced by Streptomyces hygroscopicus 17997. Journal of Microbiology and Biotechnology. 21(6). 599–603. 8 indexed citations
16.
Wang, Hongyuan, et al.. (2010). 7-O-descarbamoyl-7-hydroxygeldanamycin, a minor component from the gdmN disruption mutant of Streptomyces hygroscopicus 17997. The Journal of Antibiotics. 63(10). 623–625. 1 indexed citations
18.
He, Weiqing, et al.. (2008). The LuxR family members GdmRI and GdmRII are positive regulators of geldanamycin biosynthesis in Streptomyces hygroscopicus 17997. Archives of Microbiology. 189(5). 501–510. 52 indexed citations
19.
Li, Yonghai, Weiqing He, Yucheng Wang, Yiguang Wang, & Rong‐Guang Shao. (2008). A New Post-PKS Modification Process in the Carbamoyltransferase Gene Inactivation Strain of Streptomyces hygroscopicus 17997. The Journal of Antibiotics. 61(6). 347–355. 10 indexed citations
20.
He, Weiqing, et al.. (2006). Identification of AHBA Biosynthetic Genes Related to Geldanamycin Biosynthesis in Streptomyces hygroscopicus 17997. Current Microbiology. 52(3). 197–203. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026